Read + Share
Amedeo Smart
Independent Medical Education
Calabretta E, Guidetti A, Ricci F, Di Trani M, et al. Chemotherapy after PD-1 inhibitors in relapsed/refractory Hodgkin lymphoma: Outcomes and clonal evolution dynamics. Br J Haematol 2022 Apr 25. doi: 10.1111/bjh.18183.PMID: 35468225
Email
LinkedIn
Facebook
Twitter
Privacy Policy